Key facts
- This page summarizes Curran Simpson's Form 4 filing for REGENXBIO Inc. (RGNX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2024, 18:39.
Curran Simpson - 01 Aug 2024 Form 4 Insider Report for REGENXBIO Inc. (RGNX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- RGNX
- Reported as of
- 01 Aug 2024
- Net transaction value
- -$1,500
- SEC form
- 4
- Accepted by SEC
- 05 Aug 2024, 18:39:05 UTC
- Prior SEC filing
- 30 Jul 2024
- Next SEC filing
- 14 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patrick J. Christmas as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Curran Simpson filed Form 4 for REGENXBIO Inc. (RGNX) on 05 Aug 2024.
Change
- Previous filing in this sequence was filed on 30 Jul 2024.
- Current net transaction value: -$1,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RGNX
transaction
Common Stock
Sale
- Transaction value
- $1,500
- Shares
- -100
- Change %
- -0.06%
- Price
- $15.00
- Shares after
- 170,037
- Date
- 01 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 1 footnote
Footnote F1
This transaction was effected pursuant to a Rule 10b5-1 trading plan as adopted on March 15, 2024.